Personensuche

Personensuche

Bitte geben Sie den Namen der gesuchten Person ein.

Es wurde 1 Person gefunden.


Funktionen

  • Nebenberuflich Lehrende/r, Klinik für Urologie

Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.

    Artikel in Zeitschriften

  • Szarvas, Tibor; Reis, Henning
    Beyond driver mutations : Exploring the landscape of mutational signatures in adenocarcinomas of the bladder
    In: The Journal of Pathology Jg. 263 (2024) Nr. 4-5, S. 400 - 402
  • Murtola, Teemu J.; Siltari, Aino; Raittinen, Paavo; Tammela, Teuvo L.J.; Linder, Stig; Csizmarik, Anita; Kramer, Gero; Szarvas, Tibor
    Elevated Levels of Serum Thymidine Kinase 1 Predict Poor Survival for Patients with Metastatic Prostate Cancer
    In: European Urology Open Science Jg. 70 (2024) S. 135 - 141
  • Olah, Csilla; Mairinger, Fabian; Wessolly, Michael; Joniau, Steven; Spahn, Martin; Kruithof-de Julio, Marianna; Hadaschik, Boris; Soós, Aron; Nyirády, Péter; Győrffy, Balázs; Reis, Henning; Szarvas, Tibor
    Enhancing risk stratification models in localized prostate cancer by novel validated tissue biomarkers
    In: Prostate Cancer and Prostatic Diseases (2024) in press
  • Olah, Csilla; Kubik, András; Mátrai, Péter; Engh, Marie Anne; Barna, Viktória; Hegyi, Péter; Reis, Henning; Nyirády, Péter; Szarvas, Tibor
    Estimation of the incidence of urachal cancer : A systematic review and meta-analysis of registry-based studies
    In: Urologic Oncology: Seminars and Original Investigations Jg. 42 (2024) Nr. 7, S. 221.e1 - 221.e7
  • Koll, Florestan Johannes; Weers, Lillian; Weigert, Andreas; Banek, Severine; Köllermann, Jens; Kluth, Luis; Wenzel, Mike; Garcia, Cristina Cano; Szarvas, Tibor; Wessolly, Michael; Ingenwerth, Marc; Jeroch, Jan; Döring, Claudia; Chun, Felix K.-H.; Wild, Peter J.; Reis, Henning
    Histopathologic, Molecular, and Clinical Profiling of Lymphoepithelioma-like Carcinoma of the Bladder
    In: Modern Pathology Jg. 37 (2024) Nr. 11, 100588
  • Filipov, Teodóra; Teutsch, Brigitta; Szabó, Anett; Forintos, Attila; Ács, Júlia; Váradi, Alex; Hegyi, Péter; Szarvas, Tibor; Ács, Nándor; Nyirády, Péter; Deák, Pál Ákos
    Investigating the role of ultrasound-based shear wave elastography in kidney transplanted patients : correlation between non-invasive fibrosis detection, kidney dysfunction and biopsy results ; a systematic review and meta-analysis
    In: Journal of Nephrology (JN) Jg. 37 (2024) Nr. 6, S. 1509 - 1522
  • Fazekas, Tamás; Shim, Sung Ryul; Basile, Giuseppe; Baboudjian, Michael; Kói, Tamás; Przydacz, Mikolaj; Abufaraj, Mohammad; Ploussard, Guillaume; Kasivisvanathan, Veeru; Rivas, Juan Gómez; Gandaglia, Giorgio; Szarvas, Tibor; Schoots, Ivo G.; Van Den Bergh, Roderick C. N.; Leapman, Michael S.; Nyirády, Péter; Shariat, Shahrokh F.; Rajwa, Pawel
    Magnetic Resonance Imaging in Prostate Cancer Screening : A Systematic Review and Meta-Analysis
    In: JAMA Oncology Jg. 10 (2024) Nr. 6, S. 745 - 754
  • Püllen, Lukas; Costa, Pedro F.; Darr, Christopher; Heß, Jochen A.; Kesch, Claudia; Rehme, Christian R.; Wahl, Milan; Yirga, Leubet; Reis, Henning; Szarvas, Tibor; van Leeuwen, Fijs W. B.; Herrmann, Ken; Hadaschik, Boris; Tschirdewahn, Stephan; Krafft, Ulrich
    Near-infrared fluorescence lymph node template region dissection plus backup lymphadenectomy in open radical cystectomy for bladder cancer using an innovative handheld device : A single center experience
    In: Journal of Surgical Oncology Jg. 129 (2024) Nr. 7, S. 1325 - 1331
  • Fazekas, Tamás; Széles, Ádám D; Teutsch, Brigitta; Csizmarik, Anita; Vékony, Bálint; Kói, Tamás; Ács, Nándor; Hegyi, Péter; Hadaschik, Boris; Nyirády, Péter; Szarvas, Tibor
    Poly (ADP-ribose) Polymerase Inhibitors Have Comparable Efficacy with Platinum Chemotherapy in Patients with BRCA-positive Metastatic Castration-resistant Prostate Cancer : A Systematic Review and Meta-analysis
    In: European Urology Oncology Jg. 7 (2024) Nr. 3, S. 365 - 375
  • Reis, Henning; Al-Ahmadie, Hikmat; Szarvas, Tibor; Grünwald, Viktor; Köllermann, Jens; Koll, Florestan; Hadaschik, Boris; Chun, Felix; Wild, Peter J.; Paner, Gladell P.
    Seltenere Tumoren und Tumortypen des ableitenden Harnsystems in der 5. Aufl. der WHO-Klassifikation 2022
    In: Die Pathologie Jg. 45 (2024) Nr. 6, S. 381 - 388
  • Varadi, Melinda; Nagy, Nikolett; Reis, Henning; Hadaschik, Boris; Niedworok, Christian; Modos, Orsolya; Szendroi, Attila; Ablat, Jason; Black, Peter C.; Keresztes, David; Csizmarik, Anita; Olah, Csilla; Gaisa, Nadine T.; Kiss, Andras; Timar, Jozsef; Toth, Erika; Csernak, Erzsebet; Gerstner, Arpad; Mittal, Vinay; Karkampouna, Sofia; Kruithof de Julio, Marianna; Gyorffy, Balazs; Bedics, Gabor; Rink, Michael; Fisch, Margit; Nyirady, Peter; Szarvas, Tibor
    Clinical sequencing identifies potential actionable alterations in a high rate of urachal and primary bladder adenocarcinomas
    In: Cancer Medicine Jg. 12 (2023) Nr. 7, S. 9041 CA Szarvas - 9054
  • Csizmarik, Anita; Nagy, Nikolett; Keresztes, Dávid; Váradi, Melinda; Bracht, Thilo; Sitek, Barbara; Witzke, Kathrin; Puhr, Martin; Tornyi, Ilona; Lázár, József; Takács, László; Kramer, Gero; Sevcenco, Sabina; Maj-Hes, Agnieszka; Hadaschik, Boris; Nyirády, Péter; Szarvas, Tibor
    Comparative proteome and serum analysis identified FSCN1 as a marker of abiraterone resistance in castration-resistant prostate cancer
    In: Prostate Cancer and Prostatic Diseases Jg. 27 (2023) Nr. 3, S. 451 - 456
  • Kubik, András; das Virgens, Isabel Pinto Amorim; Szabó, Anett; Váradi, Melinda; Csizmarik, Anita; Keszthelyi, Attila; Majoros, Attila; Fehérvári, Péter; Hegyi, Péter; Ács, Nándor; Nyirády, Péter; Szarvas, Tibor
    Comprehensive Analysis of the Prognostic Value of Circulating MMP-7 Levels in Urothelial Carcinoma : A Combined Cohort Analysis, Systematic Review, and Meta-Analysis
    In: International Journal of Molecular Sciences (IJMS) Jg. 24 (2023) Nr. 9, 7859
  • Szarvas, Tibor
    Editorial Comment to Identification of tumor immunophenotypes associated with immunotherapy response in bladder cancer
    In: International Journal of Urology Jg. 30 (2023) Nr. 12, S. 1132 - 1133
  • Váradi, Melinda; Horváth, Orsolya; Módos, Orsolya; Fazekas, Tamás; Grunewald, Camilla M.; Niegisch, Günter; Krafft, Ulrich; Grünwald, Viktor; Hadaschik, Boris; Olah, Csilla; Maráz, Anikó; Furka, Andrea; Szűcs, Miklós; Nyirády, Péter; Szarvas, Tibor
    Efficacy of immune checkpoint inhibitor therapy for advanced urothelial carcinoma in real-life clinical practice : results of a multicentric, retrospective study
    In: Scientific Reports Jg. 13 (2023) Nr. 1, 17378
  • Szabó, Anett; Váncsa, Szilárd; Hegyi, Péter; Váradi, Alex; Forintos, Attila; Filipov, Teodóra; Ács, Júlia; Ács, Nándor; Szarvas, Tibor; Nyirády, Péter; Kopa, Zsolt
    Lifestyle-, environmental-, and additional health factors associated with an increased sperm DNA fragmentation : A systematic review and meta-analysis
    In: Reproductive Biology and Endocrinology Jg. 21 (2023) Nr. 1, 5
  • Koll, Florestan J.; Döring, Claudia; Olah, Csilla; Szarvas, Tibor; Köllermann, Jens; Hoeh, Benedikt; Chun, Felix K.-H.; Reis, Henning; Wild, Peter J.
    Optimizing identification of consensus molecular subtypes in muscle-invasive bladder cancer : a comparison of two sequencing methods and gene sets using FFPE specimens
    In: BMC Cancer Jg. 23 (2023) Nr. 1, 504
  • Széles, Ádám; Fazekas, Tamás; Váncsa, Szilard; Váradi, Melinda; Kovács, Petra Terézia; Krafft, Ulrich; Grünwald, Viktor; Hadaschik, Boris; Csizmarik, Anita; Hegyi, Péter; Váradi, Alex; Nyirády, Péter; Szarvas, Tibor
    Pre-treatment soluble PD-L1 as a predictor of overall survival for immune checkpoint inhibitor therapy : a systematic review and meta-analysis
    In: Cancer Immunology, Immunotherapy Jg. 72 (2023) Nr. 5, S. 1061 - 1073
  • Olah, Csilla; Reis, Henning; Hoffmann, Michèle J.; Mairinger, Fabian; Ting, Saskia; Hadaschik, Boris; Krafft, Ulrich; Grünwald, Viktor; Nyirady, Peter; Varadi, Melinda; Győrffy, Balázs; Kiss, Andras; Szekely, Eszter; Sjödahl, Gottfrid; Szarvas, Tibor
    Predictive value of molecular subtypes and APOBEC3G for adjuvant chemotherapy in urothelial bladder cancer
    In: Cancer Medicine Jg. 12 (2023) Nr. 5, S. 5222 - 5232
  • Njouendou, Abdel Jelil; Szarvas, Tibor; Tiofack, Arnol Auvaker Zebaze; Kenfack, Rovaldo Nguims; Tonouo, Pamela Derliche; Ananga, Sidonie Noa; Bell, Esther H M Dina; Simo, Gustave; Hoheisel, Jörg D; Siveke, Jens; Lueong, Smiths S.
    SOX2 dosage sustains tumor-promoting inflammation to drive disease aggressiveness by modulating the FOSL2/IL6 axis
    In: Molecular Cancer Jg. 22 (2023) Nr. 1, 52
  • Ács, Júlia; Szabó, Anett; Fehérvári, Péter; Harnos, Andrea; Skribek, Benjamin; Tenke, Martin; Szarvas, Tibor; Nyirády, Péter; Ács, Nándor; Hegyi, Péter; Majoros, Attila
    Safety and Efficacy of Vaginal Implants in Pelvic Organ Prolapse Surgery : A Meta-analysis of 161 536 Patients
    In: European Urology Focus Jg. 10 (2023) Nr. 4, S. 525 - 534
  • Fazekas, Tamás; Széles, Ádám D.; Teutsch, Brigitta; Csizmarik, Anita; Vékony, Bálint; Váradi, Alex; Kói, Tamás; Lang, Zsolt; Ács, Nándor; Kopa, Zsolt; Hegyi, Péter; Hadaschik, Boris; Grünwald, Viktor; Nyirády, Péter; Szarvas, Tibor
    Therapeutic sensitivity to standard treatments in BRCA positive metastatic castration-resistant prostate cancer patients : A systematic review and meta-analysis
    In: Prostate Cancer and Prostatic Diseases Jg. 26 (2023) Nr. 4, S. 665 - 672
  • Olah, Csilla; Hahnen, Christina; Nagy, Nikolett; Musial, Joanna; Varadi, Melinda; Nyiro, Gabor; Gyorffy, Balazs; Hadaschik, Boris; Rawitzer, Josefine; Ting, Saskia; Sjödahl, Gottfrid; Hoffmann, Michéle J.; Reis, Henning; Szarvas, Tibor
    A quantitative polymerase chain reaction based method for molecular subtype classification of urinary bladder cancer : Stromal gene expressions show higher prognostic values than intrinsic tumor genes
    In: International Journal of Cancer Jg. 150 (2022) Nr. 5, S. 856 - 867
  • Rehme, Christian R.; Fritsch, Beatrix; Thomas, Luca; Istin, Stefan; Burchert, Carolin; Hummel, Bastian; Baleanu-Curaj, Bogdan; Reis, Henning; Szarvas, Tibor; Rübben, Herbert; Hadaschik, Boris; Niedworok, Christian
    Clinical outcome and quality of life in octogenarian patients with muscle-invasive urothelial carcinoma of the bladder treated with radical cystectomy or transurethral resection of the bladder tumor : a retrospective analysis of 143 patients
    In: International Urology and Nephrology Jg. 54 (2022) Nr. 1, S. 71 - 79
  • Szarvas, Tibor; Reis, Henning
    Commentary: Treatment Outcome of Different Chemotherapy in Patients With Relapsed or Metastatic Malignant Urachal Tumor
    In: Frontiers in Oncology Jg. 12 (2022) 864708
  • Krafft, Ulrich; Mahmoud, O.; Heß, Jochen A.; Radtke, Jan Phillipp; Panic, Andrej; Püllen, Lukas; Darr, C.; Kesch, C.; Szarvas, Tibor; Rehme, Christian R.; Hadaschik, Boris; Tschirdewahn, Stephan
    Comparative analysis of Bricker versus Wallace ureteroenteric anastomosis and identification of predictors for postoperative ureteroenteric stricture
    In: Langenbeck's Archives of Surgery Jg. 407 (2022) Nr. 3, S. 1233 - 1240
  • Keresztes, Dávid; Csizmarik, Anita; Nagy, Nikolett; Módos, Orsolya; Fazekas, Tamás; Bracht, Thilo; Sitek, Barbara; Witzke, Kathrin; Puhr, Martin; Sevcenco, Sabina; Kramer, Gero; Shariat, Shahrokh; Küronya, Zsófia; Takács, László; Tornyi, Ilona; Lázár, József; Hadaschik, Boris; Lászik, András; Szűcs, Miklós; Nyirády, Péter; Szarvas, Tibor
    Comparative proteome analysis identified CD44 as a possible serum marker for docetaxel resistance in castration-resistant prostate cancer
    In: Journal of Cellular and Molecular Medicine Jg. 26 (2022) Nr. 4, S. 1332 - 1337
  • Kovács, Petra Terézia; Mayer, Tamás; Csizmarik, Anita; Váradi, Melinda; Oláh, Csilla; Széles, Ádám; Tschirdewahn, Stephan; Krafft, Ulrich; Hadaschik, Boris; Nyirády, Péter; Riesz, Péter; Szarvas, Tibor
    Elevated Pre-Treatment Serum MMP-7 Levels Are Associated with the Presence of Metastasis and Poor Survival in Upper Tract Urothelial Carcinoma
    In: Biomedicines Jg. 10 (2022) Nr. 3, 698
  • Tóth, Gábor; Sugár, Simon; Pál, Domonkos; Fügedi, Kata Dorina; Drahos, László; Schlosser, Gitta; Oláh, Csilla; Reis, Henning; Kovalszky, Ilona; Szarvas, Tibor; Turiák, Lilla
    Glycosaminoglycan Analysis of FFPE Tissues from Prostate Cancer and Benign Prostate Hyperplasia Patients Reveals Altered Regulatory Functions and Independent Markers for Survival
    In: Cancers Jg. 14 (2022) Nr. 19, 4867
  • Széles, Ádám; Kovács, Petra Terézia; Csizmarik, Anita; Váradi, Melinda; Riesz, Péter; Fazekas, Tamás; Váncsa, Szilárd; Hegyi, Péter; Oláh, Csilla; Tschirdewahn, Stephan; Darr, Christopher; Krafft, Ulrich; Grünwald, Viktor; Hadaschik, Boris; Horváth, Orsolya; Nyirády, Péter; Szarvas, Tibor
    High Pretreatment Serum PD-L1 Levels Are Associated with Muscle Invasion and Shorter Survival in Upper Tract Urothelial Carcinoma
    In: Biomedicines Jg. 10 (2022) Nr. 10, 2560
  • Wessolly, Michael; Mairinger, Fabian D.; Herold, Thomas; Hadaschik, Boris; Szarvas, Tibor; Reis, Henning
    Proteasomal Processing Immune Escape Mechanisms in Platinum-Treated Advanced Bladder Cancer
    In: Genes Jg. 13 (2022) Nr. 3, 422
  • Csizmarik, Anita; Keresztes, Dávid; Nagy, Nikolett; Bracht, Thilo; Sitek, Barbara; Witzke, Kathrin; Puhr, Martin; Tornyi, Ilona; Lázár, József; Takács, László; Kramer, Gero; Sevcenco, Sabina; Maj-Hes, Agnieszka; Jurányi, Zsolt; Hadaschik, Boris; Nyirády, Péter; Szarvas, Tibor
    Proteome profiling of enzalutamide-resistant cell lines and serum analysis identified ALCAM as marker of resistance in castration-resistant prostate cancer
    In: International Journal of Cancer Jg. 151 (2022) Nr. 8, S. 1405 - 1419
  • Püllen, Lukas; Kaspar, Cordelia; Panic, Andrej; Heß, Jochen A.; Reis, Henning; Szarvas, Tibor; Radtke, Jan Philipp; Krafft, Ulrich; Darr, Christopher; Hadaschik, Boris; Tschirdewahn, Stephan
    Retrograde Pyelography in the Presence of Urothelial Bladder Cancer Does Not Affect the Risk of Upper Tract Urothelial Cancer : A Retrospective Analysis of a Single-Centre Cohort
    In: Urologia Internationalis Jg. 106 (2022) S. 638 - 643
  • Ingenwerth, Marc; Nyirády, Péter; Hadaschik, Boris; Szarvas, Tibor; Reis, Henning
    The Prognostic Value of Cytokeratin and Extracellular Collagen Expression in Urinary Bladder Cancer
    In: Current Molecular Medicine Jg. 22 (2022) Nr. 10, S. 941 - 949
  • Neumann, Judith Martha; Niehaus, Karsten; Neumann, Nils; Knobloch, Hans Christoph; Bremmer, Felix; Krafft, Ulrich; Kellner, Udo; Nyirády, Peter; Szarvas, Tibor; Bednarz, Hanna; Reis, Henning
    A new technological approach in diagnostic pathology : Mass spectrometry imaging-based metabolomics for biomarker detection in urachal cancer
    In: Laboratory Investigation Jg. 101 (2021) Nr. 9, S. 1281 - 1288
  • Szarvas, Tibor; Csizmarik, Anita; Fazekas, Tamás; Hüttl, András; Nyirády, Péter; Hadaschik, Boris; Grünwald, Viktor; Püllen, Lukas; Jurányi, Zsolt; Kocsis, Zsuzsa; Shariat, Shahrokh F.; Sevcenco, Sabina; Maj-Hes, Agnieszka; Kramer, Gero
    Comprehensive analysis of serum chromogranin A and neuron-specific enolase levels in localized and castration-resistant prostate cancer
    In: BJU International (BJUI) Jg. 127 (2021) Nr. 1, S. 44 - 55
  • Fazekas, Tamás; Szarvas, Tibor; Csizmarik, Anita; Hadaschik, Boris; Nyirády, Péter
    Correction to : COVID-19 research ; promising tracks leading to uro-oncology
    In: International Urology and Nephrology Jg. 53 (2021) Nr. 1, S. 95
  • Neumann, Judith Martha; Niehaus, Karsten; Neumann, Nils; Knobloch, Hans Christoph; Bremmer, Felix; Krafft, Ulrich; Kellner, Udo; Nyirády, Peter; Szarvas, Tibor; Bednarz, Hanna; Reis, Henning
    Correction to: : A new technological approach in diagnostic pathology: mass spectrometry imaging-based metabolomics for biomarker detection in urachal cancer
    In: Laboratory Investigation Jg. 101 (2021) Nr. 10, S. 1414
  • Staniszewska, Magdalena; Fragoso Costa, Pedro; Eiber, Matthias; Klose, Jasmin M.; Wosniack, Jasmin; Reis, Henning; Szarvas, Tibor; Hadaschik, Boris; Lückerath, Katharina; Herrmann, Ken; Fendler, Wolfgang; Iking, Janette
    Enzalutamide enhances psma expression of psma-low prostate cancer
    In: International Journal of Molecular Sciences (IJMS) Jg. 22 (2021) Nr. 14, 7431
  • Kesch, Claudia; Yirga, Leubet; Dendl, Katharina; Handke, Analena; Darr, Christopher; Krafft, Ulrich; Radtke, Jan Philipp; Tschirdewahn, Stephan; Szarvas, Tibor; Fazli, Ladan; Gleave, Martin; Giesel, Frederik L.; Haberkorn, Uwe; Hadaschik, Boris
    High fibroblast-activation-protein expression in castration-resistant prostate cancer supports the use of FAPI-molecular theranostics
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2021) S. 385 - 389
  • Krafft, Ulrich; Olah, Csilla; Reis, Henning; Kesch, Claudia; Darr, Christopher; Grünwald, Viktor; Tschirdewahn, Stephan; Hadaschik, Boris; Horvath, Orsolya; Kenessey, Istvan; Nyirady, Peter; Varadi, Melinda; Modos, Orsolya; Csizmarik, Anita; Szarvas, Tibor
    High serum pd-l1 levels are associated with poor survival in urothelial cancer patients treated with chemotherapy and immune checkpoint inhibitor therapy
    In: Cancers Jg. 13 (2021) Nr. 11, 2548
  • Reider, Balazs; Gacsi, Eszter; Jankovics, Hajnalka; Vonderviszt, Ferenc; Szarvas, Tibor; Guttman, Andras; Jarvas, Gabor
    Integrated workflow for urinary prostate specific antigen N-glycosylation analysis using sdAb partitioning and downstream capillary electrophoresis separation
    In: Analytica Chimica Acta Jg. 1184 (2021) 338892
  • Szarvas, Tibor; Hoffmann, Michèle J.; Olah, Csilla; Szekely, Eszter; Kiss, Andras; Hess, Jochen; Tschirdewahn, Stephan; Hadaschik, Boris; Grotheer, Vera; Nyirady, Peter; Csizmarik, Anita; Varadi, Melinda; Reis, Henning
    MMP-7 Serum and Tissue Levels Are Associated with Poor Survival in Platinum-Treated Bladder Cancer Patients
    In: Diagnostics Jg. 11 (2021) Nr. 1, 48
  • Csizmarik, Anita; Hadaschik, Boris; Kramer, Gero; Nyirady, Peter; Szarvas, Tibor
    Mechanisms and markers of resistance to androgen signaling inhibitors in patients with metastatic castration-resistant prostate cancer
    In: Urologic Oncology: Seminars and Original Investigations Jg. 39 (2021) Nr. 10, S. 728.e13 - 728.e24
  • Ortiz-Brüchle, Nadina; Wucherpfennig, Sophie; Rose, Michael; Garczyk, Stefan; Bertz, Simone; Hartmann, Arndt; Reis, Henning; Szarvas, Tibor; Kiss, András; Bremmer, Felix; Golz, Reinhard; Knüchel, Ruth; Gaisa, Nadine T.
    Molecular characterization of muellerian tumors of the urinary tract
    In: Genes Jg. 12 (2021) Nr. 6, 880
  • Maj-Hes, Agnieszka; Szarvas, Tibor; Sevcenco, Sabina; Kramer, Gero
    Multiple Docetaxel Retreatments Without Prednisone for Metastatic Castration-Resistant Prostate Cancer in the Docetaxel-Only Era : Effects on PSA Kinetics and Survival
    In: Advances in Therapy Jg. 38 (2021) Nr. 7, S. 3831 - 3841
  • Darr, Christopher; Costa, Pedro Fragoso; Kesch, Claudia; Krafft, Ulrich; Püllen, Lukas; Harke, Nina; Heß, Jochen A.; Szarvas, Tibor; Haubold, Johannes; Reis, Henning; Fendler, Wolfgang; Herrmann, Ken; Radtke, Jan Philipp; Hadaschik, Boris; Tschirdewahn, Stephan
    Prostate specific membrane antigen-radio guided surgery using Cerenkov luminescence imaging : Utilization of a short-pass filter to reduce technical pitfalls
    In: Translational Andrology and Urology Jg. 10 (2021) Nr. 10, S. 3972 - 3985
  • Harke, Nina N.; Darr, Christopher; Radtke, Jan Philipp; von Ostau, Nicola; Schiefelbein, Frank; Eraky, Ahmed; Hamann, Claudius; Szarvas, Tibor; Hadaschik, Boris; Tropmann-Frick, Marina; Juenemann, Klaus-Peter; Schoen, Georg; Osmonov, Daniar
    Retroperitoneal Versus Transperitoneal Robotic Partial Nephrectomy : A Multicenter Matched-pair Analysis
    In: European Urology Focus Jg. 7 (2021) Nr. 6, S. 1363 - 1370
  • Rehme, Christian R.; Burchert, Carolin; Tosun, Mustafa; Szarvas, Tibor; Nagy, Nadine; Rübben, Herbert; Hadaschik, Boris; Niedworok, Christian
    Stone extraction with loop ureteral catheter versus ureteroscopy in small distal ureteral stones—retrospective comparison of 547 consecutive patients
    In: Translational Andrology and Urology Jg. 10 (2021) Nr. 1, S. 87 - 95
  • Szarvas, Tibor; Csizmarik, Anita; Váradi, M.; Fazekas, Tamás; Hüttl, András Béla; Nyirády, Péter; Hadaschik, Boris; Grünwald, Viktor; Tschirdewahn, Stephan; Shariat, Shahrokh F.; Sevcenco, Sabina; Maj-Hes, Agnes B.; Kramer, Gero
    The prognostic value of serum MMP-7 levels in prostate cancer patients who received docetaxel, abiraterone, or enzalutamide therapy
    In: Urologic Oncology: Seminars and Original Investigations Jg. 39 (2021) Nr. 5, S. 296.e11 - 296.e19
  • Szarvas, Tibor; Reis, Henning
    Editorial Comment from Dr Szarvas and Dr Reis to Clinicopathological features of malignant urachal tumor : A hospital-based cancer registry data in Japan
    In: International Journal of Urology Jg. 27 (2020) Nr. 2, S. 163 - 164
  • Nini, Alessandro; Hoffmann, Michèle Janine; Lampignano, Rita; große Siemer, Robert; van Dalum, Guus; Szarvas, Tibor; Cotarelo, Cristina Lopez; Schulz, Wolfgang Arthur; Niederacher, Dieter; Neubauer, Hans; Stoecklein, Nikolas Hendrik; Niegisch, Günter
    Evaluation of HER2 expression in urothelial carcinoma cells as a biomarker for circulating tumor cells
    In: Cytometry Part B: Clinical Cytometry Jg. 98 (2020) Nr. 4, S. 355 - 367
  • Krafft, Ulrich; Reis, Henning; Ingenwerth, Marc; Kovalszky, Ilona; Becker, Markus; Niedworok, Christian; Darr, Christopher; Nyirády, Péter; Hadaschik, Boris; Szarvas, Tibor
    Nuclear Localization of Robo is Associated with Better Survival in Bladder Cancer
    In: Pathology & Oncology Research Jg. 26 (2020) Nr. 1, S. 253 - 261
  • Metzenmacher, Martin; Váraljai, Renáta; Hegedüs, Balazs; Cima, Igor; Forster, Jan; Schramm, Alexander; Scheffler, Björn; Horn, Peter; Klein, Christoph A.; Szarvas, Tibor; Reis, Henning; Bielefeld, Nicola; Rösch, Alexander; Aigner, Clemens; Kunzmann, Volker; Wiesweg, Marcel; Siveke, Jens; Schuler, Martin; Lueong, Smiths S.
    Plasma next generation sequencing and droplet digital-qpcr-based quantification of circulating cell-free rna for noninvasive early detection of cancer
    In: Cancers Jg. 12 (2020) Nr. 2, S. 353
  • Nagy, Nikolett; Reis, Henning; Hadaschik, Boris; Niedworok, Christian; Módos, Orsolya; Szendrői, Attila; Bíró, Krisztina; Hager, Thomas; Herold, Thomas; Ablat, Jason; Black, Peter C.; Okon, Krzysztof; Tolkach, Yuri; Csizmarik, Anita; Oláh, Csilla; Keresztes, David; Bremmer, Felix; Gaisa, Nadine T.; Kriegsmann, Joerg; Kovalszky, Ilona; Kiss, András; Tímár, József; Szász, Marcell A.; Rink, Michael; Fisch, Margit; Nyirády, Péter; Szarvas, Tibor
    Prevalence of APC and PTEN Alterations in Urachal Cancer
    In: Pathology & Oncology Research Jg. 26 (2020) Nr. 4, S. 2773 - 2781
  • Krafft, Ulrich; Tschirdewahn, Stephan; Heß, Jochen A.; Harke, Nina; Hadaschik, Boris; Nyirády, Péter; Szendröi, Attila; Szücs, Miklós; Módos, Orsolya; Olah, Csilla; Székely, Eszter; Reis, Henning; Szarvas, Tibor
    STIP1 Tissue Expression Is Associated with Survival in Chemotherapy-Treated Bladder Cancer Patients
    In: Pathology & Oncology Research Jg. 26 (2020) Nr. 2, S. 1243 - 1249
  • Niedworok, Christian; Kempkensteffen, Carsten; Eisenhardt, Andreas; Tschirdewahn, Stephan; Rehme, Christian R.; Panic, Andrej; Reis, Henning; Baba, Hideo Andreas; Nyirády, Peter; Hadaschik, Boris; Kovalszky, Ilona; Szarvas, Tibor
    Serum and tissue syndecan-1 levels in renal cell carcinoma
    In: Translational Andrology and Urology Jg. 9 (2020) Nr. 3, S. 1167 - 1176
  • Olah, Csilla; Tschirdewahn, Stephan; Hoffmann, Michèle J.; Krafft, Ulrich; Hadaschik, Boris; Nyirady, Peter; Szendröi, Attila; Módos, Orsolya; Csizmarik, Anita; Kovalszky, Ilona; Reis, Henning; Szarvas, Tibor
    Soluble syndecan-1 levels are associated with survival in platinum-treated bladder cancer patients
    In: Diagnostics Jg. 10 (2020) Nr. 11, 864
  • Hollósi, Péter; Váncza, Lóránd; Karászi, Katalin; Dobos, Katalin; Péterfia, Bálint; Tátrai, Enikő; Tátrai, Péter; Szarvas, Tibor; Paku, Sándor; Szilák, László; Kovalszky, Ilona
    Syndecan-1 promotes hepatocyte-like differentiation of hepatoma cells targeting ETS-1 and AP-1
    In: Biomolecules Jg. 10 (2020) Nr. 10, 1356
  • Hager, Thomas; Kraywinkel, Klaus; Szarvas, Tibor; Hadaschik, Boris; Schmid, Kurt Werner; Reis, Henning
    Urachal cancer in Germany and the USA : An RKI/SEER population-based comparison study
    In: Urologia Internationalis Jg. 104 (2020) Nr. 9-10, S. 803 - 809
  • Tschirdewahn, Stephan; Panic, Andrej; Püllen, Lukas; Harke, Nina; Hadaschik, Boris; Riesz, Peter; Horváth, Andras; Szalontai, Janos; Nyirády, Peter; Baba, Hideo Andreas; Reis, Henning; Szarvas, Tibor
    Circulating and tissue IMP3 levels are correlated with poor survival in renal cell carcinoma
    In: International Journal of Cancer Jg. 145 (2019) Nr. 2, S. 531 - 539
  • Maj-Hes, Agnieszka; Sevcenco, Sabina; Szarvas, Tibor; Kramer, Gero
    Claros System: A Rapid Microfluidics-Based Point-of-Care System for Quantitative Prostate Specific Antigen Analysis from Finger-Stick Blood
    In: Advances in Therapy Jg. 36 (2019) Nr. 4, S. 916 - 922
  • Reis, Henning; Mairinger, F.; Ting, Saskia; Nagy, N.; Witzke, K.E.; Kohl, M.; Sitek, B.; Niedworok, Christian; Hadaschik, Boris; Nyirády, P.; Szarvas, Tibor
    Das Urachuskarzinom : Ein Update aktueller molekularer Ergebnisse
    In: Der Pathologe Jg. 40 (2019) Nr. Suppl. 3, S. 239 - 243
  • Szarvas, Tibor; Jardin-Watelet, Bénédicte; Bourgoin, Nicolas; Hoffmann, Michèle J; Nyirady, Peter; Oláh, Csilla; Széll, Tamás; Csizmarik, Anita; Hadaschik, Boris; Reis, Henning
    High soluble CGA levels are associated with poor survival in bladder cancer
    In: Endocrine Connections Jg. 8 (2019) Nr. 5, S. 625 - 633
  • Szarvas, Tibor; Olah, Csilla; Reis, Henning
    Neoadjuvant cisplatin-based chemotherapy in “primary” and “secondary” muscle-invasive bladder cancer—is it a surrogate for molecular subtypes?
    In: Translational Cancer Research Jg. 8 (2019) Nr. Suppl. 2, S. 176 - S179
  • Reis, Henning; Szarvas, Tibor; Grünwald, Viktor
    Prädiktive Biomarker in der onkologischen Uropathologie
    In: Der Pathologe Jg. 40 (2019) Nr. 3, S. 264 - 275
  • Reis, Henning; Szarvas, Tibor
    Therapieprädiktive Biomarker des Harnblasenkarzinoms
    In: Der Pathologe Jg. 40 (2019) Nr. Suppl. 3, S. 331 - 338
  • Reis, Henning; Szarvas, Tibor
    Urachal cancer : current concepts of a rare cancer
    In: Der Pathologe Jg. 40 (2019) Nr. Suppl. 1, S. 31 - 39
  • Krafft, Ulrich; Tschirdewahn, Stephan; Heß, Jochen A.; Harke, Nina N.; Hadaschik, Boris; Olah, Csilla; Krege, Susanne; Nyirády, Peter; Szendröi, Attila; Szücs, Miklós; Módos, Orsolya; Székely, Eszter; Reis, Henning; Szarvas, Tibor
    Validation of survivin and HMGA2 as biomarkers for cisplatin resistance in bladder cancer
    In: Urologic Oncology: Seminars and Original Investigations Jg. 37 (2019) Nr. 11, S. 810.e7 - 810.e15
  • Reis, Henning; Krafft, Ulrich; Niedworok, Christian; Módos, Orsolya; Herold, Thomas; Behrendt, Mark; Al-Ahmadie, Hikmat; Hadaschik, Boris; Nyirady, Peter; Szarvas, Tibor
    Biomarkers in Urachal Cancer and Adenocarcinomas in the Bladder : A Comprehensive Review Supplemented by Own Data
    In: Disease Markers (2018) 7308168
  • Szarvas, Tibor; Sevcenco, Sabina; Módos, Orsolya; Keresztes, Dávid; Nyirády, Péter; Kubik, András; Romics, Miklós; Kovalszky, Ilona; Reis, Henning; Hadaschik, Boris; Shariat, Shahrokh F.; Kramer, Gero
    Circulating syndecan-1 is associated with chemotherapy-resistance in castration-resistant prostate cancer
    In: Urologic Oncology: Seminars and Original Investigations Jg. 36 (2018) Nr. 6, S. 312.e9 - 312.e15
  • Reis, Henning; Szarvas, Tibor
    Das Urachuskarzinom : aktuelle Konzepte einer seltenen Tumorerkrankung
    In: Der Pathologe Jg. 39 (2018) Nr. Supplement 2, S. 291 - 300
  • Szarvas, Tibor; Sevcenco, Sabina; Módos, Orsolya; Keresztes, Dávid; Nyirády, Péter; Csizmarik, Anita; Ristl, Robin; Puhr, Martin; Hoffmann, Michèle J.; Niedworok, Christian; Hadaschik, Boris; Maj-Hes, Agnieszka; Shariat, Shahrokh F.; Kramer, Gero
    Matrix metalloproteinase 7, soluble Fas and Fas ligand serum levels for predicting docetaxel resistance and survival in castration-resistant prostate cancer
    In: BJU International (BJUI) Jg. 122 (2018) Nr. 4, S. 695 - 704
  • Reis, Henning; van der Vos, Kristan E.; Niedworok, Christian; Herold, Thomas; Módos, Orsolya; Szendroi, Attila; Hager, Thomas; Ingenwerth, Marc; Vis, Daniël J.; Behrendt, Mark A.; de Jong, Jeroen; van der Heijden, Michiel S.; Peyronnet, Benoit; Mathieu, Romain; Wiesweg, Marcel; Ablat, Jason; Okon, Krzysztof; Tolkach, Yuri; Keresztes, David; Nagy, Nikolett; Bremmer, Felix; Gaisa, Nadine T.; Chlosta, Piotr; Kriegsmann, Joerg; Kovalszky, Ilona; Timar, József; Kristiansen, Glen; Radzun, Heinz-Joachim; Knüchel, Ruth; Schuler, Martin; Black, Peter C.; Rübben, Herbert; Hadaschik, Boris; Schmid, Kurt Werner; van Rhijn, Bas W.G.; Nyirády, Péter; Szarvas, Tibor
    Pathogenic and targetable genetic alterations in 70 urachal adenocarcinomas
    In: International Journal of Cancer Jg. 143 (2018) Nr. 7, S. 1764 - 1773
  • Darr, Christopher; Krafft, Ulrich; Hadaschik, Boris; Tschirdewahn, Stephan; Sevcenco, Sabina; Csizmarik, Anita; Nyirady, Peter; Küronya, Zsófia; Reis, Henning; Maj-Hes, Agnieszka; Shariat, Shahrokh F.; Kramer, Gero; Szarvas, Tibor
    The Role of YKL-40 in Predicting Resistance to Docetaxel Chemotherapy in Prostate Cancer
    In: Urologia Internationalis Jg. 101 (2018) Nr. 1, S. 65 - 73
  • Fulop, Tibor; Zsom, Lajos; Rodriguez, Betzaida; Afshan, Sabahat; Davidson, Jamie V; Szarvas, Tibor; Dixit, Mehul; Tapolyai, Mihaly B; Rosivall, László
    Clinical Utility of Potassium-Sparing Diuretics to Maintain Normal Serum Potassium in Peritoneal Dialysis Patients
    In: Peritoneal Dialysis International Jg. 37 (2017) Nr. 1, S. 63 - 69
  • Droop, Johanna; Szarvas, Tibor; Schulz, Wolfgang A.; Niedworok, Christian; Niegisch, Günter; Scheckenbach, Kathrin; Hoffmann, Michèle J.
    Diagnostic and prognostic value of long noncoding RNAs as biomarkers in urothelial carcinoma
    In: PLoS ONE Jg. 12 (2017) Nr. 4, S. e0176287
  • Fullár, Alexandra; Firneisz, Gábor; Regős, Eszter; Dudás, József; Szarvas, Tibor; Baghy, Kornélia; Ramadori, Giuliano; Kovalszky, Ilona
    Response of Hepatic Stellate Cells to TGFB1 Differs from the Response of Myofibroblasts. Decorin Protects against the Action of Growth Factor
    In: Pathology & Oncology Research Jg. 23 (2017) Nr. 2, S. 287 - 294
  • Reis, Henning; Niedworok, Christian; Szarvas, Tibor
    Response to: Absence of GNAS and BRAF mutations but presence of KRAS mutation in urachal adenocarcinoma
    In: Pathology Jg. 49 (2017) Nr. 5, S. 561 - 562
  • Niedworok, Christian; Tschirdewahn, Stephan; Reis, Henning; Lehmann, Nils; Szücs, Miklós; Nyirády, Péter; Romics, Imre; Rübben, Herbert; Szarvas, Tibor
    Serum Chromogranin A as a Complementary Marker for the Prediction of Prostate Cancer-Specific Survival
    In: Pathology & Oncology Research Jg. 23 (2017) Nr. 3, S. 643 - 650
  • Thiem, Sebastian; Herold, Thomas; Krafft, Ulrich; Bremmer, Felix; Tolkach, Yuri; Szász, Attila M.; Kriegsmann, Joerg; Gaisa, Nadine T.; Niedworok, Christian; Szarvas, Tibor; Reis, Henning
    Telomerase reverse transcriptase (TERT) promoter mutations are rare in urachal cancer
    In: Pathology International Jg. 67 (2017) Nr. 12, S. 597 - 601
  • vom Dorp, Frank; Szarvas, Tibor; Rübben, Herbert; Nyirady, Peter; Shariat, Shahrokh F.; Kramer, Gero; Busch, Jonas; Kempkensteffen, Carsten; Krause, Hans; Reis, Henning; Niedworok, Christian; Tschirdewahn, Stephan
    Circulating and Tissue Expression Levels of YKL-40 in Renal Cell Cancer
    In: The Journal of Urology Jg. 195 (2016) Nr. 4, S. 1120 - 1125
  • Nyirády, Péter; Niedworok, Christian; Reis, Henning; Szarvas, Tibor
    Clinical Sequencing-guided Therapy of Urachal Carcinoma : New Perspective for a Rare Cancer
    In: European Urology Jg. 70 (2016) Nr. 5, S. 776 - 777
  • Szarvas, Tibor; Módos, Orsolya; Niedworok, Christian; Reis, Henning; Szendröi, Attila; Szász, Marcell A.; Nyirády, Péter
    Clinical, prognostic, and therapeutic aspects of urachal carcinoma—A comprehensive review with meta-analysis of 1,010 cases
    In: Urologic Oncology: Seminars and Original Investigations Jg. 34 (2016) Nr. 9, S. 388 - 398
  • Módos, Orsolya; Reis, Henning; Niedworok, Christian; Rübben, Herbert; Szendröi, Attila; Szász, Marcell A; Tímár, József; Baghy, Kornélia; Kovalszky, Ilona; Golabek, Tomasz; Chlosta, Piotr; Okon, Krzysztof; Peyronnet, Benoit; Mathieu, Romain; Shariat, Shahrokh F; Hollósi, Péter; Nyirády, Péter; Szarvas, Tibor
    Mutations of KRAS, NRAS, BRAF, EGFR, and PIK3CA genes in urachal carcinoma : Occurence and prognostic significance
    In: OncoTarget Jg. 7 (2016) Nr. 26, S. 39293 - 39301
  • Szarvas, Tibor; Reis, Henning; vom Dorp, Frank; Tschirdewahn, Stephan; Niedworok, Christian; Nyirady, Peter; Schmid, Kurt Werner; Rübben, Herbert; Kovalszky, Ilona
    Soluble syndecan-1 (SDC1) serum level as an independent pre-operative predictor of cancer-specific survival in prostate cancer
    In: The Prostate Jg. 76 (2016) Nr. 11, S. 977 - 985
  • Tapolyai, Mihály B; Faludi, Mária; Berta, Klára; Szarvas, Tibor; Lengvárszky, Zsolt; Molnar, Miklos Z; Dossabhoy, Neville R; Fülöp, Tibor
    The effect of ambient temperature and humidity on interdialytic weight gains in end-stage renal disease patients on maintenance hemodialysis
    In: International Urology and Nephrology Jg. 48 (2016) Nr. 7, S. 1171 - 1176
  • Niedworok, Christian; Panitz, Martin; Szarvas, Tibor; Reis, Henning; Reis, Anna Carinna; Szendröi, Attila; Nyirády, Peter; Marcell Szasz; Módos, Orsolya; Rübben, Herbert; vom Dorp, Frank
    Urachal Carcinoma of the Bladder: Impact of Clinical and Immunohistochemical Parameters on Prognosis
    In: The Journal of Urology Jg. 195 (2016) Nr. 6, S. 1690 - 1695
  • Niedworok, Christian; Szarvas, Tibor; Szucs, Miklos; Rübben, Herbert; Reis, Henning; Tschirdewahn, Stephan; vom Dorp, Frank
    Validation of the diagnostic and prognostic relevance of serum MMP-7 levels in renal cell cancer by using a novel automated fluorescent immunoassay method
    In: International Urology and Nephrology Jg. 48 (2016) Nr. 3, S. 355 - 361
  • Szarvas, Tibor; Módos, Orsolya; Horváth, András; Nyirády, Péter
    Why are upper tract urothelial carcinoma two different diseases?
    In: Translational Andrology and Urology Jg. 5 (2016) Nr. 5, S. 636 - 647
  • Acs, Balazs; Szarvas, Tibor; Szekely, Nora; Nyirady, Peter; Szasz, A Marcell
    Current State of ERG as Biomarker in Prostatic Adenocarcinoma
    In: Current Cancer Drug Targets Jg. 15 (2015) Nr. 8, S. 643 - 651
  • Niedworok, Christian; Dörrenhaus, Bettina; vom Dorp, Frank; Piotrowski, Jarowit Adam; Tschirdewahn, Stephan; Szarvas, Tibor; Rübben, Herbert; Schenck, Marcus
    Renal cell carcinoma and tumour thrombus in the inferior vena cava : clinical outcome of 98 consecutive patients and the prognostic value of preoperative parameters
    In: World Journal of Urology Jg. 33 (2015) Nr. 10, S. 1541 - 1552
  • Hoffmann, Michèle J.; Dehn, Judith; Droop, Johanna; Niegisch, Günter; Niedworok, Christian; Szarvas, Tibor; Schulz, Wolfgang A.
    Truncated Isoforms of lncRNA ANRIL Are Overexpressed in Bladder Cancer, But Do Not Contribute to Repression of INK4 Tumor Suppressors
    In: Non-Coding RNA Jg. 1 (2015) Nr. 3, S. 266 - 284
  • Szarvas, Tibor
    Editorial Comment from Dr Szarvas to Functional polymorphisms in the matrix metalloproteinase genes and their association with bladder cancer risk and recurrence : A mini-review
    In: International Journal of Urology Jg. 21 (2014) Nr. 8, S. 753
  • Szarvas, Tibor; Reis, Henning; Kramer, Gero; Shariat, Shahrokh F; vom Dorp, Frank; Tschirdewahn, Stephan; Schmid, Kurt Werner; Kovalszky, Ilona; Rübben, Herbert
    Enhanced stromal syndecan-1 expression is an independent risk factor for poor survival in bladder cancer
    In: Human Pathology Jg. 45 (2014) Nr. 4, S. 674 - 682
  • Palacios, DiegoAguil; Chen, Limei; Dai, Yunfeng; Andersen, LarsDyrskj; Sanchez-Carbayo, Marta; Szarvas, Tibor; Zwarthoff, EllenC; Jeronimo, Carmen; Parker, AlexanderS; Ross, Shanti; Chai, KarlX; Goodison, Steve; Rosser, CharlesJ
    External validation of a multiplex urinary protein panel for the detection of bladder cancer in a multicenter cohort
    In: The Journal of Urology Jg. 191 (2014) Nr. Suppl. 4, S. E235
  • Chen, L.-M.; Chang, M.; Dai, Y.; Chai, K. X.; Dyrskjot, L.; Sanchez-Carbayo, M.; Szarvas, Tibor; Zwarthoff, E. C.; Lokeshwar, V.; Jeronimo, C.; Parker, A. S.; Ross, S.; Borre, M.; \Orntoft, T. F.; Jaeger, T.; Beukers, W.; Lopez, L. E.; Henrique, R.; Young, P. R.; Urquidi, V.; Goodison, S.; Rosser, C. J.
    External validation of a multiplex urinary protein panel for the detection of bladder cancer in a multicenter cohort
    In: Cancer Epidemiology, Biomarkers & Prevention Jg. 23 (2014) Nr. 9, S. 1804 - 1812
  • Tschirdewahn, Stephan; Reis, Henning; Niedworok, Christian; Nyirady, Peter; Szendröi, Attila; Schmid, Kurt Werner; Shariat, Shahrokh F.; Kramer, Gero; vom Dorp, Frank; Rübben, Herbert; Szarvas, Tibor
    Prognostic effect of serum and tissue YKL-40 levels in bladder cancer
    In: Urologic Oncology: Seminars and Original Investigations Jg. 32 (2014) Nr. 5, S. 663 - 669
  • Szarvas, Tibor; Tschirdewahn, Stephan; Niedworok, Christian; Kramer, Gero; Sevcenco, Sabina; Reis, Henning; Shariat, Shahrokh F.; Rübben, Herbert; vom Dorp, Frank
    Prognostic value of tissue and circulating levels of IMP3 in prostate cancer
    In: International Journal of Cancer Jg. 135 (2014) Nr. 7, S. 1596 - 1604
  • Szarvas, Tibor; Rübben, Herbert; Reis, Henning
    Re: Association of Oncofetal Protein Expression with Clinical Outcomes in Patients with Urothelial Carcinoma of the Bladder
    In: The Journal of Urology Jg. 192 (2014) Nr. 2, S. 617 - 618
  • vom Dorp, Frank; Tschirdewahn, Stephan; Szarvas, Tibor; Rübben, Herbert; Rehme, Christian R.
    Urothelkarzinom der Harnblase : Organerhaltende Therapiestrategien
    In: Der Urologe Jg. 53 (2014) Nr. 9, S. 1322 - 1328
  • Szarvas, Tibor
    Editorial comment to characterization and risk stratification of prostate cancer in patients undergoing radical cystoprostatectomy
    In: International Journal of Urology Jg. 20 (2013) Nr. 9, S. 872
  • Niedworok, Christian; Roc̈k, Katharina; Kretschmer, Inga; Freudenberger, Till; Nagy, Nadine; Szarvas, Tibor; vom Dorp, Frank; Reis, Henning; Rübben, Herbert; Fischer, Jens W.
    Inhibitory role of the small leucine-rich proteoglycan biglycan in bladder cancer
    In: PLoS ONE Jg. 8 (2013) Nr. 11, S. e80084
  • Jäger, Tobias; Tschirdewahn, Stephan; vom Dorp, Frank; Piechotta, G.; Rübben, Herbert; Szarvas, Tibor
    MMP-7-Bestimmung im Urin basierend auf Siliziumchiptechnologie : Eine Möglichkeit zur präoperativen Identifizierung von Lymphknotenmetastasen beim Harnblasenkarzinom
    In: Der Urologe Jg. 52 (2013) Nr. 6, S. 853 - 858
  • Jäger, T.; Kramer, J.; Bätz, O.; Rübben, Herbert; Von Ostau, C.; Szarvas, Tibor
    Testosteronmangel - ein unterschätztes Risiko für Männer? : Prävalenz des Hypogonadismus
    In: Der Urologe Jg. 52 (2013) Nr. 12, S. 1684 - 1689
  • Niedworok, Christian; Kretschmer, Inga; Röck, Katharina; vom Dorp, Frank; Szarvas, Tibor; Heß, Jochen A.; Freudenberger, Till; Melchior-Becker, Ariane; Rübben, Herbert; Fischer, Jens W
    The impact of the receptor of hyaluronan-mediated motility (RHAMM) on human urothelial transitional cell cancer of the bladder
    In: PLoS ONE Jg. 8 (2013) Nr. 9, S. e75681
  • Szarvas, Tibor; Jäger, Tobias; Laszlo, Viktoria; Kramer, Gero; Klingler, H. Christoph; vom Dorp, Frank; Romics, Imre; Ergün, Süleyman; Rübben, Herbert
    Circulating angiostatin, bFGF, and Tie2/TEK levels and their prognostic impact in bladder cancer
    In: Urology Jg. 80 (2012) Nr. 3, S. 737.e13 - 737.e18
  • Szarvas, Tibor; vom Dorp, Frank; Niedworok, Christian; Melchior-Becker, Ariane; Fischer, Jens W.; Singer, Bernhard B.; Reis, Henning; Bankfalvi, Agnes; Schmid, Kurt Werner; Romics, Imre; Ergün, Süleyman; Rübben, Herbert
    High insulin-like growth factor mRNA-binding protein 3 (IMP3) protein expression is associated with poor survival in muscle-invasive bladder cancer
    In: BJU International (BJUI) Jg. 110 (2012) Nr. 6B, S. E308 - E317
  • Szarvas, Tibor; László, Viktória; vom Dorp, Frank; Reis, Henning; Szendröi, Attila; Romics, Imre; Tilki, Derya; Rübben, Herbert; Ergün, Süleyman
    Serum endostatin levels correlate with enhanced extracellular matrix degradation and poor patients' prognosis in bladder cancer
    In: International Journal of Cancer Jg. 130 (2012) Nr. 12, S. 2922 - 2929
  • Szarvas, Tibor; Kramer, G.; Hess, J.; Tschirdewahn, Stephan; Reis, Henning; Romics, I.; Sevcenco, S.; Totsch, M.; Rübben, Herbert; vom Dorp, Frank
    Tissue MMP-7 expression predicts survival in bladder cancer patients treated with cisplatin-based chemotherapy
    In: Journal of Urology Jg. 187 (2012) Nr. Suppl. 4, S. E575 - E575
  • vom Dorp, Frank; Pal, Philip; Tschirdewahn, Stephan; Rossi, Roberto; Börgermann, Christof; Schenck, Markus; Becker, Markus; Szarvas, Tibor; Hakenberg, Oliver W.; Rübben, Herbert
    Correlation of pathological and cytological-cytometric grading of transitional cell carcinoma of the urinary tract
    In: Urologia Internationalis Jg. 86 (2011) Nr. 1, S. 36 - 40
  • Szarvas, Tibor; Becker, Markus; vom Dorp, Frank; Meschede, Jan; Scherag, Andre; Bankfalvi, Agnes; Reis, Henning; Schmid, Kurt Werner; Romics, Imre; Rübben, Herbert; Ergün, Süleyman
    Elevated serum matrix metalloproteinase 7 levels predict poor prognosis after radical prostatectomy
    In: International Journal of Cancer Jg. 128 (2011) Nr. 6, S. 1486 - 1492
  • Reis, Henning; Tschirdewahn, Stephan; Szarvas, Tibor; Rübben, Herbert; Schmid, Kurt Werner; Grabellus, Florian
    Expression of GLUT1 is associated with increasing grade of malignancy in non-invasive and invasive urothelial carcinomas of the bladder
    In: Oncology Letters Jg. 2 (2011) Nr. 6, S. 1149 - 1153
  • Szarvas, Tibor; vom Dorp, Frank; Ergün, Süleyman; Rübben, Herbert
    Matrix metalloproteinases and their clinical relevance in urinary bladder cancer
    In: Nature Reviews Urology Jg. 8 (2011) Nr. 5, S. 241 - 254
  • vom Dorp, Frank; Tschirdewahn, Stephan; Olbricht, Tobias; Szarvas, Tibor; Rübben, Herbert
    Photodynamische Diagnostik des Harnblasenkarzinoms
    In: Der Urologe Jg. 50 (2011) Nr. 9, S. 1068 - 1071
  • Szarvas, Tibor; Hoffmann, F.; Becker, M.; Schenck, Marcus; vom Dorp, Frank; Rübben, Herbert; Jäger, T.
    Plasmakonzentrationen von E-Cadherin bei Tumorerkrankungen der Harnblase : Kann die Prognoseabschätzung hiermit verbessert werden?
    In: Der Urologe Jg. 50 (2011) Nr. 1, S. 64 - 70
  • Szarvas, Tibor; Singer, Bernhard B.; Becker, Markus; vom Dorp, Frank; Jäger, Tobias; Szendråi, Attila; Riesz, Péter; Romics, Imre; Rübben, Herbert; Ergün, Süleyman; Szendrői, Attila
    Urinary matrix metalloproteinase-7 level is associated with the presence of metastasis in bladder cancer
    In: BJU International (BJUI) Jg. 107 (2011) Nr. 7, S. 1069 - 1073
  • Heß, Jochen A.; Tschirdewahn, Stephan; Szarvas, Tibor; Rossi, R; Rübben, Herbert; vom Dorp, Frank
    Urothelkarzinom der Harnblase : Kombinierte endoskopische und urinzytologische Beurteilung: Lässt es sich sicher einschätzen?
    In: Der Urologe Jg. 50 (2011) Nr. 6, S. 702 - 705
  • Szarvas, Tibor; Jäger, Tobias; Becker, Markus; Tschirdewahn, Stephan; Niedworok, Christian; Kovalszky, Ilona; Rübben, Herbert; Ergün, Süleyman; vom Dorp, Frank
    Validation of Circulating MMP-7 Level as an Independent Prognostic Marker of Poor Survival in Urinary Bladder Cancer
    In: Pathology & Oncology Research Jg. 17 (2011) Nr. 2, S. 325 - 332
  • Szarvas, Tibor; Becker, Markus; vom Dorp, Frank; Gethmann, Carolin; Tötsch, Martin; Bankfalvi, Agnes; Schmid, Kurt Werner; Romics, Imre; Rübben, Herbert; Ergün, Süleyman
    Matrix metalloproteinase-7 as a marker of metastasis and predictor of poor survival in bladder cancer
    In: Cancer Science Jg. 101 (2010) Nr. 5, S. 1300 - 1308
  • Becker, Markus; Szarvas, Tibor; Wittschier, Markus; vom Dorp, Frank; Tötsch, Martin; Schmid, Kurt Werner; Rübben, Herbert; Ergün, Süleyman
    Prognostic impact of plasminogen activator inhibitor type 1 expression in bladder cancer
    In: Cancer Jg. 116 (2010) Nr. 19, S. 4502 - 4512
  • Jäger, Tobias; Becker, Markus; Eisenhardt, Andreas; Tilki, Derya; Tötsch, Martin; Schmid, Kurt Werner; Romics, Imre; Rübben, Herbert; Ergün, Süleyman; Szarvas, Tibor
    The prognostic value of cadherin switch in bladder cancer
    In: Oncology Reports Jg. 23 (2010) Nr. 4, S. 1125 - 1132
  • Szarvas, Tibor; Jäger, Tobias; Tötsch, Martin; vom Dorp, Frank; Kempkensteffen, Carsten; Kovalszky, Ilona; Romics, Imre; Ergün, Süleyman; Rübben, Herbert
    Angiogenic switch of angiopietins-Tie2 system and its prognostic value in bladder cancer
    In: Clinical Cancer Research Jg. 14 (2008) Nr. 24, S. 8253 - 8262
  • Jäger, Tobias; Szarvas, Tibor; vom Dorp, Frank; Börgermann, Christof; Schenck, Marcus; Schmid, Kurt Werner; Rübben, Herbert
    Einsatz der Siliziumchiptechnologie zur Detektion von Tumormarkern auf Proteinbasis beim Harnblasenkarzinom
    In: Der Urologe Jg. 46 (2007) Nr. 9, S. 1152 - 1156
  • Aufsätze

  • vom Dorp, Frank; Tschirdewahn, Stephan; Szarvas, Tibor; Rubben, H.; Kraemer, R.; Rehme, Christian R.
    Erratum zu : Urothelkarzinom der Harnblase. Organerhaltende Therapiestrategien
    In: Der Urologe Jg. 53 (2014) Nr. 12, S. 1832
  • Vorworte / Nachworte

  • Fazekas, Tamás; Szarvas, Tibor; Csizmarik, Anita; Hadaschik, Boris; Nyirády, Péter
    COVID-19 research : promising tracks leading to uro-oncology
    In: International Urology and Nephrology Jg. 52 (2020) Nr. 6, S. 995 - 997
  • Abstracts

  • Florestan J., Koll; Doering, Claudia; Herwig, Leon; Csilla, Olah; Szarvas, Tibor; Koellermann, Jens; Garcia, Cristina Cano; Wenzel, Mike; Hoeh, Benedikt; Banek, Severine; Kluth, Luis; Chun, Felix K. H.; Wild, Peter J.; Reis, Henning
    Molecular Subtypes in Muscle-Invasive Urothelial Bladder Cancer (MIBC) : Comparison of 2 Sequencing Methods - Evaluation of Their Predictive Role in Adjuvant Chemotherapy and Impact of Tumor Microenvironment
    In: The Journal of Molecular Diagnostics Jg. 26 (2024) Nr. Suppl. 6, S. 49 - S50
  • Reis, Henning; Niedworok, Christian; Wiesweg, Marcel; Schuler, Martin; Rübben, Herbert; Hadaschik, Boris; Schmid, Kurt Werner; Szarvas, Tibor;
    Potentially Targetable Molecular Alterations in 70 Cases of Urachal Cancer
    Geared to Learn ; USCAP 107th Annual Meeting ; March 17–23, 2018, Vancouver,
    In: Modern Pathology Jg. 31 (2018) Nr. Suppl. 2, S. 378
  • Niedworok, C.; Szarvas, Tibor; vom Dorp, Frank; Rübben, Herbert; Fischer, J. W.;
    Expression of Receptor of Hyaluronan Mediated Motility (RHAMM) is associated with progression of bladder cancer and poor prognosis
    77th Annual Meeting, March 30 – April 1, 2011, Frankfurt a. M., Germany,
    In: Naunyn-Schmiedeberg's Archives of Pharmacology Jg. 383 (2011) Nr. Suppl. 1, S. 69 - 70
  • Beiträge in Sammelwerken und Tagungsbänden

  • Olah, Csilla; Szarvas, Tibor
    A Panel-Based Method for the Reproduction of Distinct Molecular Subtype Classifications of Muscle-Invasive Urothelial Bladder Cancer
    In: Urothelial Carcinoma: Methods and Protocols / Hoffmann, Michèle J.; Gaisa, Nadine T.; Nawroth, Roman; Ecke, Thorsten H. (Hrsg.) 2023, S. 27 - 43
  • Bücher/Sammelwerke/Tagungsbände

  • Szarvas, Tibor
    Bedeutung molekularer Mechanismen bei der prognostischen Abschätzung urologischer Tumorerkrankungen
    Duisburg, Essen (2011) CD-ROM